Dominant Dystrophic Epidermolysis Bullosa Latest Advances
Find the Latest Research About Dominant Dystrophic Epidermolysis Bullosa
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 754 publications
Clinical manifestations, genetic characteristics and laboratory markers of patients with epidermolysis bullosa: a single tertiary referral center experience.
Journal: Annals of medicine
Published: October 13, 2026
An isogenic hiPSC-derived keratinocyte model reveals CXCL10/CXCL11 inflammatory dysregulation in epidermolysis bullosa simplex.
Journal: Frontiers in cell and developmental biology
Published: June 24, 2026
Homology-directed CRISPR-Cas9 correction of the KRT5 p.E475G mutation in human iPSC line from a patient with severe epidermolysis bullosa simplex.
Journal: Stem cell research
Published: April 10, 2026
Dupilumab Use in Severe Epidermolysis Bullosa Simplex.
Journal: JAMA dermatology
Published: February 25, 2026
Supraglottic and Glottic Involvement in Epidermolysis Bullosa Simplex: A Pediatric Case Report and Review of Airway Management.
Journal: Ear, nose, & throat journal
Published: January 27, 2026
Nail Dystrophy Treated With Marigold Therapy in a Patient With Epidermolysis Bullosa Simplex.
Journal: The Australasian journal of dermatology
Published: January 25, 2026
Autosomal Dominant Severe Epidermolysis Bullosa Simplex Treated With Dupilumab.
Journal: Pediatric dermatology
Published: December 27, 2025
Last Updated: 11/08/2026